Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy.

Current opinion in oncology - 1 Mar 2023

D'Alise Anna Morena, Scarselli Elisa

Abstract excerpt

PURPOSE OF REVIEW: Cancer vaccines are facing renewed interest, thanks to the progress recently achieved in the immunotherapy field, including the success of immune checkpoint inhibitors (CPIs). The advances in understanding the CPI mode of action revealed a central role of neoantigens for the outcome of such treatments. Neoantigens became the preferred antigens for cancer vaccines and have been evaluated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Immune Checkpoint Inhibitors
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 36721894
DOI: 10.1097/CCO.0000000000000923
PMCID: PMC9894148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy.PMID 36721894Read ↗

Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.Semantic proximity Read ↗

An immunogenic personal neoantigen vaccine for patients with melanoma.Semantic proximity Read ↗

New emerging targets in cancer immunotherapy: the role of neoantigensSemantic proximity Read ↗

Progress in Neoantigen Targeted Cancer ImmunotherapiesSemantic proximity Read ↗

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Semantic proximity Read ↗

Characterizing neoantigens for personalized cancer immunotherapy.Semantic proximity Read ↗

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and ImmunotherapySemantic proximity Read ↗

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapySemantic proximity Read ↗

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.Semantic proximity Read ↗

Advances in personalized neoantigen vaccines for cancer immunotherapy.Semantic proximity Read ↗

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.Semantic proximity Read ↗

The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.